Ocular Angiogenesis & Retinal Vascular Permeability Models

APPLICATIONS:

  • Wet or exudative form of age-related macular degeneration (AMD, ARMD)
  • Diabetic eye diseases (diabetic retinopathy (DR) and diabetic macular edema (DME))
  • Retinopathy of prematury (ROP)
  • Ischemic retinopathies
  • Corneal angiogenesis (inflammatory disorders, stromal ulceration, corneal graft, infectious keratitis, chemical burns)
  • ​Retinal vessel integrity test
  • Proof of concept for angiogenesis and/or lymphangiogenesis

 

PRECLINICAL EFFICACY MODELS:

  • Choroidal neovascularization: experimental argon laser-induced choroidal neovascularization (CNV model)
  • Retinal neovascularization: animal model of oxygen-induced retinopathy (OIR), DL-α-aminoadipic acid (AAA)-induced chronic retinal neovascularization (DL-AAA model)
  • Retinal vascular permeability: VEGF-induced retinal vascular permeability model/VEGF-induced vessel leakage
  • Corneal neovascularization: sutures or alkali burn

 

EXAMPLE OF EVALUATIONS:

  • Length of new vessels and network density (slit lamp examination)
  • Lesion volume (optical coherence tomography (OCT), histology analysis)
  • Blood-retinal vascular permeability (fluorophotometer)
  • Vascular leakage (fundus fluorescein angiography (FFA))
  • Retinal vessel tortuosity (fundus biomicroscopy with a slit lamp)
  • Marker levels (eg. ELISA, RT-PCR)

Find comprehensive information about ocular pathologies here: Ocular Pathologies.

PUBLICATIONS:

ocular angiogenesis
  • Evaluation of Molecular Properties versus In Vivo Performance of Aflibercept, Brolucizumab, and Ranibizumab in a Retinal Vascular Hyperpermeability Model. SCHUBERT W et al. (collaboration) Trans. Vis. Sci. Tech. 2022;11(10):36. doi: 10.1167/tvst.11.10.36 Article
  • Successful Proof-of-Concept for Topical Delivery of Novel Peptide ALM201 with Potential Usefulness for Treating Neovascular Eye Disorders. OBASANMI G et al. (collaboration) Ophthalmol. Sci. 2022; 2, 2, 100150. doi: 10.1016/j.xops.2022.100150 Article
  • DutaFabs are engineered therapeutic Fab fragments that can bind two targets simultaneously. BECKMANN R et al. (collaboration) Nature 2021:12:708 doi: 10.1038/s41467-021-20949-3 Article
  • Thermostable small-molecule inhibitor of angiogenesis and vascular permeability that suppresses a pERK-FosB/ΔFosB–VCAM-1 axis. Y LI et al. Sci. Adv. 2020; 6 : eaaz7815 DOI: 10.1126/sciadv.aaz7815 Article
  • The uni-nephrectomized and salt-loaded SDT fatty rat, a novel type 2 diabetic model of diabetic nephropathy, develops features of diabetic retinopathy. SHINOHARA M et al. Japanese Society of Toxicologic Pathology meeting 2020; Tokuo, JAPAN   
  • The uni-nephrectomized SDT fatty rat, a novel type 2 diabetic model of diabetic nephropathy, develops features of diabetic retinopathy over 10 weeks. BRIAND F et al. ARVO meeting 2018; Hawaii - USA. Abstract No. 3573 - A0190  Poster | Abstract
  • SMA+ perivascular cells evaluation in VEGF induced blood-retinal barrier breakdown in rabbit model. ELENA PP et al. EVER meeting 2016; Nice – France Poster | Abstract
  • Safety and Tolerability of Overdosed Artificial Tears by Abraded Rabbit Corneas. DAULL P et al. J. Ocul. Pharmacol. Ther. 2018; DOI: 10.1089/jop.2018.0040 Article
  • Effects of the multi-kinase inhibitor regorafenib on ocular neovascularization. KLAR J et al. ARVO meeting 2015; DENVER, CO - USA. Invest. Ophthalmol. Vis. Sci. 2015; 56(7): 426.92  Abstract
  • Ether-lipid-deficient-mice display pigmentary glaucoma features as well as abnormal retinal vasculature. ACAR N et al. ARVO meeting 2007; Fort Lauderdale, FL - USA. Invest. Ophthalmol. Vis. Sci. May 2007, Vol.48, 2978. doi: Abstract
  • In vivo characterization of the anti-inflammatory effect of a multikinase inhibitor targeting angiogenesis and inflammation. JENSEN L et al. 8th World Congress on Inflammation 2007; Copenhagen, Denmark. Inflamm Res. 2007; 56(suppl.3): S443, abstract P07.21 Abstract
  • Effects of Dexamethasone in a Rat model of choroidal neovascularization. FERAILLE L et al. Ocular Anti-Angiogenesis meeting 2006; London - United Kingdom Poster
  • Variation of Krüppel-like factors levels in mouse corneal model of angiogenesis. CHIAMBARETTA F et al. ARVO meeting 2005; Fort Lauderdale, FL. Invest. Ophthalmol. Vis. Sci. 2005; 46: ARVO e-abstract No. 2609  Abstract
  • Variation of krüppel-like factors ARNm levels in a mouse corneal model of angiogenesis (Variation du niveau des ARNm des krüppel-like factors dans un modèle murin d’angiogénèse cornéenne). CHIAMBARETTA F et al. SFO meeting 2005; Paris – France. Abstract No. 380 - DOI: 10.1016/S0181-5512(05)73501-4
  • PKC412 content in retina, choroid and plasma of pup mice with retinal neovascularization induced by hypoxic stimuli. ELENA PP et al. ARVO meeting 2004; Fort Lauderdale, FL - USA. Invest. Ophthalmol. Vis. Sci. 2004; 45: ARVO e-abstract No. 4053 Abstract
  • PKC412 reduces retinal neovascularization induced by hypoxic stimuli in pup mice. CAILLAUD T et al. ARVO meeting 2004; Fort Lauderdale, FL - USA. Invest. Ophthalmol. Vis. Sci. 2004; 45: ARVO e-abstract No. 4062  Abstract

 

 

Related topics

IN VIVO PHARMACOLOGY STUDIES
in vivo pharmacology
PRECLINICAL EQUIPMENT
ophthalmology equipment
ASK FOR AN OCULAR ANGIOGENIS EXPERT